RinLis®

Insulin lispro. 
Dosage form: solution for subcutaneous and intravenous injections in 3 ml cartridges and disposable insulin pen. 

·         Widely used fast acting insulin analogue.
·         Characterised by reverse lysine and proline residues on amino acid sequence in the insulin amino acid chain. 
·         Fast absorption from subcutaneous injection sites. 
·         Onset of action after subcutaneous administration – in 15 minutes.
·         0.5-2.5 hours – maximum action. 
·         3-4 hours – duration of action.